CVRX Stock Analysis: Buy, Sell, or Hold?
CVRX - CVRx, Inc. Common Stock
$5.43
0.00 (0.00%)
▲
5d:
-3.55%
30d:
+12.42%
90d:
-24.11%
BUY
HIGH Confidence
Analysis Updated: Jul 13, 2026 12:00 AM ET
Earnings: Aug 03, 2026
19d
Get Alerted When CVRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: CVRX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
✅ BUY SIGNAL: CVRX shows strong fundamentals and good volume confirmation. Solid entry point despite fair pricing.
In-depth Analysis How we analyze
Valuation Analysis: CVRX is currently trading at $5.43, which is considered fair relative to its 30-day fair value range of $4.95 to $5.62.
Technical Outlook: Technically, CVRX is in a downtrend. Immediate support is located at $4.77, while resistance sits at $5.95.
Market Sentiment: CVRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.17 (+105.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, CVRX is in a downtrend. Immediate support is located at $4.77, while resistance sits at $5.95.
Market Sentiment: CVRX has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. In the options market, Implied Volatility is low (0th percentile), suggesting options premiums are relatively cheap. This makes it an attractive time for long options strategies if you have a directional bias. Wall Street analysts see significant upside, with an average price target of $11.17 (+105.6%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$4.95 -
$5.62
Company Quality Score
56/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
89.6%
All Signals
- NEUTRAL: Price in fair range
- BULLISH: Options cheap (IV 0th percentile)
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 105.6% below Wall St target ($11.17)
Trading Range Analysis
30-Day Trading Range
$4.95 -
$5.62
Current vs Trading Range
FAIR
Expected Move (7 Days)
±$0.78
(14.3%)
Support & Resistance Levels
Support Level
$4.77
Resistance Level
$5.95
Current Trend
Downtrend
Technical data as of
Jun 12, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-2.87
Wall Street Target
$11.17
(+105.6%)
Revenue Growth (YoY)
19.6%
Profit Margin
-89.1%
Share & Embed Analysis
Last updated: July 13, 2026 8:39 PM ET
Data refreshes hourly during market hours. Next update: 9:39 PM
Data refreshes hourly during market hours. Next update: 9:39 PM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is CVRX showing a specific setup today?
Insider Activity (6 Months)
2
Buys
1
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Philip B Adamson
SELL
1262 shares
2026-03-02
Mudit K Jain
BUY
46800 shares
2026-02-20
Mudit K Jain
BUY
600 shares
2026-02-18
Top Rated Medical Devices Stocks
Top-rated stocks in Medical Devices by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BSX
Boston Scientific Corp |
STRONG BUY
34 analysts |
$74 | 65 BUY |
|
SYK
Stryker Corporation |
BUY
32 analysts |
$386 | 63 BUY |
|
DXCM
DexCom Inc |
STRONG BUY
27 analysts |
$85 | 57 HOLD |
|
PODD
Insulet Corporation |
STRONG BUY
24 analysts |
$239 | 57 HOLD |
|
EW
Edwards Lifesciences Corp |
HOLD
32 analysts |
$98 | 62 BUY |
Advanced CVRX Option Strategies
Professional options setups generated by AI based on today's CVRX price and gamma walls.